Garlic‐derived compounds: Epigenetic modulators and their antitumor effects
Phytotherapy Research · 2024-03 · 38 (3) · 1329-1344
DOI: 10.1002/ptr.8108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 09.01.2024. Verfasst von Huan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, Chin…. Hauptthemen laut MEDLINE: Garlic, Neoplasms, Allyl Compounds, Biological Products. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Municipal Administration of Hospitals Incubating Program, R&D Program of Beijing Municipal Education Commission.
Abstract (Originalsprache)
Cancer is a highly heterogeneous disease that poses a serious threat to human health worldwide. Despite significant advances in the diagnosis and treatment of cancer, the prognosis and survival rate of cancer remain poor due to late diagnosis, drug resistance, and adverse reactions. Therefore, it is very necessary to study the development mechanism of cancer and formulate effective therapeutic interventions. As widely available bioactive substances, natural products have shown obvious anticancer potential, especially by targeting abnormal epigenetic changes. The main active part of garlic is organic sulfur compounds, of which diallyl trisulfide (DATS) content is the highest, accounting for more than 40% of the total composition. The garlic‐derived compounds have been recognized as an antioxidant for cancer prevention and treatment. However, the molecular mechanism of the antitumor effect of garlic‐derived compounds remains unclear. Recent studies have identified garlic‐derived compound DATS that plays critical roles in enhancing CpG demethylation or promoting histone acetylation as an epigenetic inhibitor. Here, we review the therapeutic progress of garlic‐derived compounds against cancer through epigenetic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
- Institute of Resources and Environment, Beijing Academy of Science and Technology, Beijing, China.
- Department of Endoscopic Diagnosis and Treatment, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
ORCID-Profile: Shuye Lin
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals Incubating Program
- R&D Program of Beijing Municipal Education Commission
- Beijing Hospitals Authority Youth Programme
Zitieren
APA
Zhang, H., Wang, H., Qin, L., & Lin, S. (2024). Garlic‐derived compounds: Epigenetic modulators and their antitumor effects. Phytotherapy Research, 38(3), 1329-1344. https://doi.org/10.1002/ptr.8108
Vancouver
Zhang H, Wang H, Qin L, Lin S. Garlic‐derived compounds: Epigenetic modulators and their antitumor effects. Phytotherapy Research. 2024;38(3):1329-1344. doi:10.1002/ptr.8108
BibTeX
@article{Zhang2024,
author = {Zhang, Huan and Wang, Haichao and Qin, Lin and Lin, Shuye},
title = {Garlic‐derived compounds: Epigenetic modulators and their antitumor effects},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {3},
pages = {1329--1344},
doi = {10.1002/ptr.8108}
}
EUVIMED